Skip to content
Low-Grade Serous Ovarian Cancer — 5-Minute Journal Club: Microlearning Activity 1 episode artwork

EPISODE · Sep 13, 2026 · 28 MIN

Low-Grade Serous Ovarian Cancer — 5-Minute Journal Club: Microlearning Activity 1

from Oncology Today with Dr Neil Love

Featuring perspectives from Dr Rachel N Grisham, including the following topics: Mechanism, clinical evidence and practical use of avutometinib with defactinib for recurrent low-grade serous ovarian cancer (LGSOC) (0:00) A Phase III trial of letrozole alone as front-line treatment for LGSOC (11:11) Current and future role of avutometinib with defactinib for LGSOC (19:23) A Phase II/III trial of trametinib for recurrent LGSOC: Biomarker analyses and clinical implications (21:37) CME information and select publications

Episode metadata supplied by the publisher feed · Published Sep 13, 2026

Embed this episode

Ready to play

Low-Grade Serous Ovarian Cancer — 5-Minute Journal Club: Microlearning Activity 1

0:00 28:46

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Oncology Today with Dr Neil Love?

This episode is 28 minutes long.

When was this Oncology Today with Dr Neil Love episode published?

This episode was published on September 13, 2026.

Can I download this Oncology Today with Dr Neil Love episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!